-
The Cleveland Clinic and University Hospitals, along with researchers at The Ohio State University, are part of the first study to determine whether newly approved Alzheimer's drug lecanemab not only can slow progression of the disease, but actually prevent it.
-
New research from the Alzheimer's Association has county-by-county data on the prevalence of the disease for the first time.
-
More than 126,000 people in the Tri-State area are living with dementia or caring for someone who is, according to the Giving Voice Foundation, which offers support and free activities to promote brain health.
-
CPD undergoing training to improve interactions with people who have Alzheimer's, dementia or autismPolice across the nation are arresting more older people. And the consequences can become dangerous – and even deadly -- when the people getting arrested have dementia.
-
Leqembi is priced at $26,500 a year and Medicare and Medicaid only covers clinical trials.
-
Something as simple as a change in routine or being around too many unfamiliar faces can cause confusion and added stress for someone with dementia, the Alzheimer's Association of Greater Cincinnati says.
-
A Science Magazine investigation alleges that the 2006 study, which has lead to hundreds of millions of research dollars, contained “shockingly blatant” examples of image tampering.
-
Ninety-five-year-old Dick Soller, his 88-year-old wife Jean — who has Alzheimer's —and their daughter Mary, will participate in the 10K on Saturday, all while raising money for a cause.
-
The Centers for Medicare and Medicaid Services could restrict Medicare coverage of Aduhelm to only individuals enrolled in clinical trials.
-
A protein replacement therapy may rescue the brain from Alzheimer's, so says a UC researcher whose new study was published Monday.Professor of Neurology…